Optimized reagents for immunopotency assays on mesenchymal stromal cells for clinical use

ABSTRACT: Multipotent mesenchymal stromal cells (MSC) offer new therapeutic opportunities based on their ability to modulate an imbalanced immune system. Immunomodulatory potency is typically demonstrated in vitro by measuring the presence of surrogate markers (i.e., indoleamine-2,3-dioxygenase, IDO...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrents, Sílvia, del Moral, Andrés Escudero, Codinach, Margarita, Rodríguez, Luciano, Querol, Sergi, Vives, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148700/
https://www.ncbi.nlm.nih.gov/pubmed/37120479
http://dx.doi.org/10.1007/s12026-023-09385-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148700/
https://www.ncbi.nlm.nih.gov/pubmed/37120479
http://dx.doi.org/10.1007/s12026-023-09385-1

Ejemplares similares